Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018

Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018

Background: P2Y12 inhibitors are an important component of dual antiplatelet therapy. Yet, their accessibility and affordability across countries stratified by income levels have not been studied. Methods: Sales data were retrieved from the IQVIA Multinational Integrated Data Analysis System for the...

Full description

Bibliographic Details
Main Authors: Xuxiao Ye, Jessica J.P. Shami, Vincent K.C. Yan, Wei Kang, Joseph E. Blais, Jiaxi Zhao, Wallis C.Y. Lau, Li Wei, Ian C.K. Wong, Esther W. Chan
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:American Heart Journal Plus
Subjects:
P2Y12 inhibitors
Sales trends
Income level
Antiplatelets
Drug utilization
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602221000185

Internet

http://www.sciencedirect.com/science/article/pii/S2666602221000185

Similar Items